Arg293
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Di-methylation Site Page: > Arg293  -  hnRNP A0 (mouse)

Site Information
rSNSGPYrGGYGGGY   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 476746

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 )
Relevant cell line - cell type - tissue:
brain ( 1 , 2 , 3 , 4 , 5 ) , embryo ( 1 , 6 , 7 , 8 , 9 , 10 , 11 , 12 ) , MEF (fibroblast) ( 13 , 14 , 15 , 16 , 17 , 18 )

References 

1

Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87
24129315   Curated Info

2

Mulhern D (2012) CST Curation Set: 15835; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

3

Mulhern D (2012) CST Curation Set: 15836; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

4

Mulhern D (2012) CST Curation Set: 15837; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

5

Mulhern D (2012) CST Curation Set: 15838; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

6

Mulhern D (2012) CST Curation Set: 15843; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

7

Mulhern D (2012) CST Curation Set: 15844; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

8

Mulhern D (2012) CST Curation Set: 15845; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

9

Mulhern D (2012) CST Curation Set: 15846; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

10

Guo A (2012) CST Curation Set: 14309; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

11

Guo A (2012) CST Curation Set: 14312; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

12

Guo A (2012) CST Curation Set: 14313; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

13

Zhou J (2009) CST Curation Set: 6951; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

14

Zhou J (2009) CST Curation Set: 6949; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

15

Zhou J (2009) CST Curation Set: 6950; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

16

Zhou J (2009) CST Curation Set: 6948; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

17

Zhou J (2009) CST Curation Set: 6540; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

18

Zhou J (2009) CST Curation Set: 6539; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.